⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | LIC MF Dividend Yield Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | LIC MF | HDFC MF |
| Category | Equity - Dividend Yield Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹33.71 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Sumit Bhatnagar | Nikhil Mathur |
| Inception | 21 Dec 2018 | 04 Oct 2023 |
| Returns | ||
| 1Y | -1.84% | 22.64% |
| 3Y | 17.88% | 30.41% |
| 5Y | 13.80% | — |
| Since Inception | 16.81% | 29.15% |
| Risk | ||
| 16.57 | 14.07 | |
| 1.14 | 0.59 | |
| 0.70 | 1.59 | |
| 7.12 | 21.67 | |
| 1.38 | 3.48 | |
| -12.70% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.96% | 1.03% |
| Exit Load | Nil upto 12% of units and 1% for remaining units on or before 12M, Nil after 12M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹200 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
LIC MF94%
HDFC MF94%
6.3%Only 6.3% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingLIC MFHDFC MF
Neuland Laboratories Ltd.2.24%3.24%
Anthem Biosciences Ltd.2.02%3.17%
Apollo Hospitals Enterprise Ltd.2.00%3.69%
Category context: Equity vs Equity. Open the full Screener →